Your session is about to expire
← Back to Search
IVUS-Guided PCI for Atherosclerosis (IMPROVE Trial)
IMPROVE Trial Summary
This trial is looking at whether or not using IVUS to guide percutaneous coronary intervention (PCI) will reduce recurrent events after PCI.
IMPROVE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIMPROVE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IMPROVE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have received clot-dissolving medication within 24 hours before a heart procedure.You have a stent thrombosis.I have a type of chest pain or minor heart attack and am getting a procedure to open my heart's arteries.My heart procedure was guided by imaging or ultrasound.I have had a severe heart attack or experienced heart failure.I am scheduled for a planned procedure to restore blood flow.My heart stent was placed in a very complex or high-risk part of my heart.You had a specific type of eye test called optical coherence tomography (OCT) during the initial procedure.I am 18 years old or older.
- Group 1: Angiographic-guided PCI
- Group 2: IVUS guided PCI
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scope of enrollment for this empirical research?
"Correct. Perusing clinicaltrials.gov, it is evident that this medical experiment commenced on October 14th 2020 and has been actively seeking participants since then. In total, 3100 individuals must be recruited from 30 trial sites."
How many areas within the state are currently collaborating on this research endeavor?
"Patients can receive this medication at St. Luke's Hospital of Duluth in Duluth, Minnesota, AdventHealth Sebring in Sebring, Florida and Texas Tech University Health Sciences Center in El Paso, Texas; as well as 30 other medical centres throughout the country."
Is it currently feasible to join the clinical trial?
"Affirmative. Clinicaltrials.gov hosts the information that indicates this trial, which was first announced on October 14th 2020 is currently recruiting participants. In total, 3100 patients are needed across 30 different medical facilities."
Share this study with friends
Copy Link
Messenger